Anticof (7.5+7.5+2.5) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Meridians Labs. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Chlorpheniramine Maleate, Ethyl Morphine Hcl,Noscapine. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 23 (arround $0.322 US Dollar)
The main active ingredients or salts in Anticof (7.5+7.5+2.5) are :
Chlorpheniramine Maleate-2.5 mg
Noscapine-7.5 mg
Ethyl Morphine Hcl-7.5 mg
Chlorpheniramine Maleate Indication (Prescribed for or used as): Allergic conditions. Adjunct in the emergency treatment of anaphylactic shock.
For more details on Chlorpheniramine Maleate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Chlorpheniramine Maleate..
Ethyl Morphine Hcl Indication (Prescribed for or used as):
For more details on Ethyl Morphine Hcl, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ethyl Morphine Hcl..
Noscapine Indication (Prescribed for or used as): Anti tussive agent. Studies are underway to assess the effectiveness of this drug in cancer especially prostate and stroke.
For more details on Noscapine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Noscapine..
Anticof (7.5+7.5+2.5) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 2 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Anticof (7.5+7.5+2.5), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Chlorpheniramine Maleate-2.5 mg Noscapine-7.5 mg Ethyl Morphine Hcl-7.5 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.